TLR4 and acute kidney injury: In AKI, LPS can significantly increase the expression of TLR-4, P-selectin, and integrin αIIbβ3 in platelets, and these effects were mitigated by a TLR4 inhibitor, effectively preventing kidney and lung injury, as well as inflammatory cell infiltration into the kidney and lung tissue [114].